ArticlePurinergic signalling2026
Identification of the promoter region of the human P2RX7 gene.
Article in Purinergic signalling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The human P2X7 purinergic receptor is an ATP-gated ion channel expressed across a wide range of cell types, including immune, epithelial, glial, and various cancer cells. Despite its broad expression and diverse functions, little is known about the transcriptional regulation of the P2RX7 gene. In this study, the transcription initiation site of the P2RX7 gene was mapped 149/148 nucleotides upstream of the ATG start codon by using a sequencing-based primer extension method. To characterise the promoter region of the P2RX7 gene, eight DNA fragments were cloned into a dual-colour luciferase reporter vector system. The promoter activity of each fragment was assessed in transfected HEK-293 and COS-7 cells. Predicted promoter binding sequences were identified, and fluorescence-based super-electrophoretic mobility shift assay confirmed that the transcription factors YY1 and C/EBPβ directly bind to the P2RX7 promoter region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.